Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

Heron boosted by new data for ‘breakthrough’ pain drug

Shares jumped by a third after trial announcement

- PMLiVE

Another R&D flop for Incyte, but Jakafi keeps delivering

Jakafi achieved overall response rate of 55% on organ transplant patients who developed GVHD

- PMLiVE

Daily Brief: Airbus relocation woes, inflated taxes will pay for NHS boost, NICE OK’s Sanofi’s Dupixent and more

The latest news from across pharma, biotech and healthcare

- PMLiVE

Roche reshuffles its executive committee, again

Sophie Kornowski-Bonnet joins Reed and heads for the exit

- PMLiVE

Weekly comms appointments

Axon promotes team members

The Challenges Of UX In Healthcare: Technology To Change Lives

Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today.

Blue Latitude Health

- PMLiVE

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

Seven treatments for rare conditions have been selected for the final

- PMLiVE

Porterhouse Pathfinders: A new internship programme at Porterhouse Medical

At the Porterhouse Medical Group, we are delighted to announce the launch of our newly branded internship programme, Porterhouse Pathfinders.The Porterhouse Medical Group comprises medical communications, market research and insights...

Porterhouse Medical Group

- PMLiVE

Novo’s diabetes pill defeats Merck’s Januvia in trial

Oral semaglutide also outshines its best-selling diabetes injectable Victoza

- PMLiVE

Alexion uses priority review voucher for Soliris follow-up

Files ravulizumab for paroxysmal nocturnal haemoglobinuria

- PMLiVE

Eminent surgeon Atul Gawande to lead Amazon’s health venture

Surgeon, public health doctor and 'big thinker' on healthcare to lead new venture

- PMLiVE

Developing advocacy in the pharmaceutical industry

The importance of advocacy programmes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links